Skip to main content

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

GH holding history

Guardant Health, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GH overviewAll 13F holders of GHFull Q2 2026 holdings

Shares (Q2 2026)
1,449,534
Value
$217.5M
% of portfolio
0.1%
Quarters held
21
Since Q1 2021
Holdings of GH by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,449,534$217.5M0.1%+673,593+86.8%AddedHolders
Q1 2026775,941$71.7M0.1%+211,599+37.5%AddedHolders
Q4 2025564,342$57.6M<0.1%+259,822+85.3%AddedHolders
Q3 2025304,520$19.0M<0.1%−2,634,033−89.6%ReducedHolders
Q2 20252,938,553$152.9M0.1%−658,360−18.3%ReducedHolders
Q1 20253,596,913$153.2M0.1%+2,115,024+142.7%AddedHolders
Q4 20241,481,889$45.3M<0.1%+1,151,488+348.5%AddedHolders
Q3 2024330,401$7.58M<0.1%−2,960,496−90.0%ReducedHolders
Q2 20243,290,897$95.0M0.1%+500,359+17.9%AddedHolders
Q1 20242,790,538$57.6M0.1%+2,762,668+9,912.7%AddedHolders
Q4 202327,870$753.9K<0.1%−410,445−93.6%ReducedHolders
Q3 2023438,315$13.0M<0.1%+28,418+6.9%AddedHolders
Q2 2023409,897$14.7M<0.1%+142,831+53.5%AddedHolders
Q1 2023267,066$6.26M<0.1%−16,572−5.8%ReducedHolders
Q4 2022283,638$7.71M<0.1%−68,214−19.4%ReducedHolders
Q3 2022351,852$18.9M<0.1%+216,050+159.1%AddedHolders
Q2 2022135,802$5.48M<0.1%−398,623−74.6%ReducedHolders
Q1 2022534,425$35.4M<0.1%+14,669+2.8%AddedHolders
Q4 2021519,756$52.0M0.1%+519,756NewHolders
Q3 20210$00.0%−166,664−100.0%Sold outHolders
Q2 2021166,664$20.7M<0.1%−79,867−32.4%ReducedHolders
Q1 2021246,531$37.6M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.